Jane Street
CRBP icon

Jane Street’s Corbus Pharmaceuticals CRBP Stock Holding History

Jane Street’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
+11,800
New +$112K ﹤0.01% 10536
2021
Q4 		– Sell
-373
Closed -$11K – 10147
2021
Q3 		$11K Sell
373
-37
-9% -$1.46K ﹤0.01% 9802
2021
Q2 		$23K Sell
410
-1,433
-78% -$79.5K ﹤0.01% 9626
2021
Q1 		$109K Buy
1,843
+1,186
+181% +$78K ﹤0.01% 8603
2020
Q4 		$25K Sell
657
-11,770
-95% -$440K ﹤0.01% 7361
2020
Q3 		$671K Buy
12,427
+11,890
+2,214% +$2.15M ﹤0.01% 4720
2020
Q2 		$135K Buy
+537
New +$109K ﹤0.01% 6589

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Jane Street's CRBP Position: Q2 2026 in Review

Jane Street increased its Corbus Pharmaceuticals (CRBP) stake by 90% in Q2 2026, buying an estimated $624K and bringing the position to 139,133 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #5977.

Jane Street first reported a position in CRBP in Q3 2016 and has held it in 22 quarters since. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Jane Street held 139,133 shares of Corbus Pharmaceuticals worth $1.31M as of Q2 2026.
  • Jane Street bought 65,940 Corbus Pharmaceuticals shares in Q2 2026, an estimated $624K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5977 holding.
  • Jane Street first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 22 quarters since.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.